​​​Supplements

​2016

*December 2016

The International Retinal Imaging Symposium (IRIS IV) 2016​

The International Retinal Imaging Symposium (IRIS) convenes on an annual basis and brings together experts in this field from all over the world to speak on the newest technologies and innovations in retinal imaging.


​2015

* September 2015​ (Monograph mailed with RETINA)
EXPERT CASE DISCUSSIONS IN DIABETIC RETINOPATHY: Multidisciplinary Considerations
This continuing medical education activity is jointly provided by Wills Eye Hospital and MedEdicus LLC. This continuing medical education activity is supported through an unrestricted educational grant from Regeneron Pharmaceuticals, Inc.

* July 2015 (Monograph mailed with RETINA)
NEW FRONTIERS IN THE MANAGEMENT OF NONINFECTIOUS UVEITIS INVOLVING THE POSTERIOR SEGMENT
This continuing medical education activity is jointly provided by New York Eye and Ear Infirmary of Mount Sinai and MedEdicus LLC and is supported through an unrestricted educational grant from Santen Pharmaceutical Co, Ltd.

* May 2015​ (Monograph mailed with RETINA)
NEW FRONTIERS IN THE TREATMENT OF DIABETIC MACULAR EDEMA
This continuing medical education activity is jointly provided by Wills Eye Hospital and MedEdicus LLC and is supported through an unrestricted educational grant from Aerpio Therapeutics.
 
* April 2015​ (Monograph mailed with RETINA)
GLOBAL DEVELOPMENTS AND APPROACHES IN THE TREATMENT OF CHRONIC NONINFECTIOUS POSTERIOR UVEITIS: HIGHLIGHTS FROM AN EXPERT ROUNDTABLE DISCUSSION
Jointly provided by New York Eye and Ear Infirmary of Mount Sinai and MedEdicus LLC. This continuing medical education activity is supported through an unrestricted educational grant from Santen Pharmaceutical Co, Ltd.

* February 2015 (Monograph mailed with RETINA)
CURRENT MANAGEMENT OF DIABETIC MACULAR EDEMA AND DIABETIC RETINOPATHY: A MULTIDISCIPLINARY DISCUSSION OF CLINICAL CASES
Jointly provided by the University of Nebraska Medical Center, Center for Continuing Education and MedEdicus LLC. This continuing education activity is supported through an unrestricted educational grant from Regeneron Pharmaceuticals, Inc.

2014

INTRAVITREAL INJECTION TECHNIQUE AND MONITORING: UPDATED GUIDELINES OF AN EXPERT PANEL
This supplement was paid for through the use of advertising support by Genentech. Genentech has had no prior input in the consensus meeting or preparation of this document in any way.

* August 2014(Monograph mailed with RETINA)
REAL-WORLD EXPERIENCE AND RESHAPING THE VMA TREATMENT PARADIGM FOR OPTIMAL OUTCOMES: EXPERT PERSPECTIVES
Jointly provided by Wills Eye Hospital and MedEdicus LLC. This continuing education activity is supported through an unrestricted educational grant from ThromboGenics NV.

* April 2014​ (Monograph mailed with RETINA)
INDIVIDUALIZING THERAPY FOR PATIENTS WITH NEOVASCULAR AMD AND DME: CONSIDERATIONS FOR SHORT- AND LONG-TERM MANAGEMENT
Proceedings from an Experts Roundtable Discussion. Jointly sponsored by The University of Louisville Department of Continuing Education and MedEdicus. This continuing education activity is supported through an unrestricted educational grant from Regeneron Pharmaceuticals, Inc.

* January 2014 (Monograph mailed with RETINA)
MACULAR EDEMA FOLLOWING CENTRAL RETINAL VEIN OCCLUSION (CRVO): THE ROLE OF EYLEA® (AFLIBERCEPT) INJECTION
Supplement prepared and sponsored by Regeneron.

2013

* October 2013​ (Monograph mailed with RETINA)
CYTOKINE TRAP TECHNOLOGY AND NEOVASCULAR (WET) AGE-RELATED MACULAR   DEGENERATION: THE ROLE OF EYLEA (AFLIBERCEPT) INJECTION
Prepared and sponsored by Regeneron
 
* April 2013​ (Monograph mailed with RETINA)
CASE DEBATES IN THE MANAGEMENT OF AGE-RELATED MACULAR DEGENERATION AND DIABETIC MACULAR EDEMA
Jointly sponsored by The New York Eye and Ear Infirmary and MedEdicus LLC.
Supported through an unrestricted educational grant from Genentech, Inc.

* February 2013​ (Monograph mailed with RETINA)
REFINING ANTI-VEGF DOSING STRATEGIES FOR YOUR PATIENTS WITH WET AMD
Jointly sponsored by The New York Eye and Ear Infirmary and MedEdicus LLC.
Supported through an unrestricted educational grant from Genentech, Inc.

2012

VITREOMACULAR DISORDERS: PATHOGENESIS AND TREATMENT
Proceedings from a Roundtable Symposium
Supported through an unrestricted educational grant from ThromboGenics, Inc.
pp. S173-S232
 
* June 2012 (Monograph mailed with RETINA)
MANAGEMENT OF DIABETIC MACULAR EDEMA APPLICATION OF CURRENT EVIDENCE TO PATIENT CARE
Highlights from a Roundtable Discussion
Supported through an unrestricted educational grant from Alimera Sciences.

​​* May 2012 (Monograph mailed with RETINA)
ADVANCES IN THE TREATMENT OF WET AGE-RELATED MACULAR DEGENERATION
Proceedings from a Roundtable Discussion
Jointly sponsored by The New York Eye and Ear Infirmary and MedEdicus LLC.        
Supported through an unrestricted educational grant from Regeneron Pharmaceuticals, Inc, with additional support from Optovue, Inc.

TRIBUTE TO LARRY A. YANNUZZI, MD
​pp. OP-893:OP-906,1-1572,S1-S28​